This site is intended for healthcare professionals only
LoginRegister
Aster DM Healthcare appoints Sudeep Dey as CIO, CISOAster DM Healthcare, India appoints Sudeep Dey as CIO, CISO
No Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in IndiaNo Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in India
Zydus Wellness incorporates wholly owned subsidiary in UKZydus Wellness incorporates wholly owned subsidiary in UK
USFDA approves Tonix Pharma Tonmya for fibromyalgia in adultsTeva Pharma announces USFDA filing acceptance for Ajovy in Pediatric Episodic Migraine prevention
Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapySanofi completes acquisition of Vigil Neuroscience
Rs 92 Cr Drug Factory Busted in Bhopal: DRI Arrests 7, Exposes International Mephedrone SyndicateNPPA Caps Prices of Ipratropium, Sodium Nitroprusside, Two Other Essential Drugs
Akums Drugs & Pharma Hormonal manufacturing plant gets EAEU GMP CertificationAkum Pharma Asked to Submit Safety Data for Alzheimer's Drug Combo In Elderly Indian Patients
net profit dropsAurobindo Pharma net profit drops 10 percent to Rs 824 crore in Q1
MSN Labs Gets CDSCO Panel Nod to Begin Phase III Trial of Cenobamate Tablets, With Safety CaveatMSN Labs Gets CDSCO Panel Nod to Begin Phase III Trial of Cenobamate Tablets, With Safety Caveat
USFDA appoints Sean Keveney as Chief CounselUSFDA appoints Sean Keveney as Chief Counsel
Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung CancerBristol Myers Squibb Breyanzi application accepted for priority review by USFDA for Marginal Zone...
Cipla Bommasandra facility gets VAI classification from USFDACipla Bommasandra facility gets VAI classification from USFDA
X